Evaluate a Healthcare Marketing Agency by What You Can Verify

Decabrand is a healthcare marketing agency, so this advice comes with an obvious conflict: we are describing how to evaluate businesses like ours. The only useful response is to make the evaluation verifiable.

Do not choose an agency because it says it is strategic, healthcare-specialized, data-driven, or a partner. Every credible contender can say those things. Choose by inspecting what the practice will own, how claims are reviewed, how results connect to appointments, who makes decisions, and what happens when the first plan is wrong.

Start with control

The practice should normally own its advertising accounts, analytics properties, Business Profiles, domains, website access, call-tracking configuration, creative source files, and core data. The agency can receive appropriate role-based access. It should not need to become the permanent owner to do the work.

Ask the agency to map each asset, current owner, administrators, billing party, and offboarding process before signing. Confirm that individual users receive their own access rather than sharing passwords. Google, for example, supports separate owners and managers for Business Profiles; its official access guidance explains the roles.

Control also includes definitions. Who decides what counts as a lead? Can the practice distinguish existing-patient calls, vendor calls, wrong-service inquiries, scheduled consultations, and completed appointments? If the agency reports a number the practice cannot audit, the dashboard is decoration.

Ask for a decision system, not a channel list

A proposal that promises SEO, ads, social posts, email, video, and reputation management may simply be a menu. A strategy explains why a smaller set of actions fits the practice’s capacity, economics, market, and patient journey.

Ask what the team believes is broken, what evidence supports that diagnosis, what it will test first, and what result would change the plan. A good answer contains uncertainty. It may say, “We do not yet know whether demand or call handling is the constraint; the first month will establish both.”

Our guide to patient acquisition cost explains why media cost alone is an incomplete measure. The agency should connect sources to qualified inquiries, appointments, attendance, appropriate care, and the practice’s own economic model without pretending attribution is perfect.

Test the compliance boundary

“HIPAA compliant” is not an adequate agency answer. Ask which data flows the agency touches, which tools receive them, who approves vendors, how access is limited, and who reviews campaigns that use patient information. A BAA may be necessary in some relationships, but it does not make every data use permissible or every configuration secure.

Ask who approves clinical statements, success rates, before-and-after presentations, testimonials, targeting, and financial offers. Marketing staff should not improvise clinical claims. The FTC’s health-products compliance guidance states that health-related advertising must be truthful, nonmisleading, and appropriately substantiated. State professional and advertising rules may add requirements.

A credible agency identifies where its expertise ends. It should be willing to route legal questions to counsel, clinical questions to an authorized reviewer, and privacy questions to the practice’s privacy or security owner. Our FTC and FDA healthcare advertising guide provides context, but it is not a substitute for advice on a specific campaign.

Inspect the people who will do the work

Meet the account lead and the specialists assigned to the engagement, not only the salesperson. Ask how many accounts they manage, who writes and approves content, who can change a campaign, and what happens during leave or turnover.

Request work samples relevant to the problem, but examine the evidence behind them. A case study should state the baseline, period, scope, metric definition, and material context. Screenshots of rising traffic do not establish patient growth. Confidentiality may limit client detail; it does not excuse vague measurement.

References are useful when questions are specific: Did the agency give you account access? Did reports match what your front desk saw? How did it handle a disappointing quarter? Was offboarding orderly? The answer to a hard situation is more informative than a satisfaction quote.

A worked proposal comparison

Suppose one agency guarantees 40 leads per month and another proposes a six-week diagnostic phase. The guarantee feels concrete. On inspection, “lead” includes every form and call over 30 seconds, regardless of intent. The agency owns the landing page and call-tracking number, and the contract does not specify data export.

The second proposal maps profile ownership, call categories, form routing, appointment outcomes, clinical approvals, and a decision point after baseline measurement. It does not promise volume. It explains that paid search will expand only if the practice answers demand and sees appropriate inquiries.

The second plan is not automatically better, but it is more falsifiable. The practice can test its diagnosis, inspect its data, and change course. That is what an evaluation should reward.

Write the first 90 days into the relationship

A useful scope names deliverables, dependencies, approval timelines, meeting cadence, media budgets, pass-through costs, and what is excluded. It states which practice leader can make decisions and which delays will affect the schedule.

Set a baseline before declaring improvement. Agree on a small number of business measures and diagnostic measures. Decide in advance what triggers expansion, repair, or cancellation. Organic search may need a longer observation window than paid campaign routing, but “marketing takes time” cannot become an unlimited excuse.

Include exit terms: notice, final exports, access removal, number-porting responsibilities, asset transfer, and treatment of licensed creative. A healthy relationship does not require captivity.

Choose the operating match

An agency is not always the right model. A practice with daily creative needs and enough scale may need an internal leader. A small specialist may need focused outside expertise rather than a full-service retainer. A hybrid can work when decision rights are explicit.

The correct partner should make the practice more capable of understanding its own growth system, not less. Evaluate the agency on whether its work can be inspected, challenged, and transferred. If the strategy depends on trust without evidence, the sales process is asking for the very thing marketing is supposed to earn.

---

Evaluating Decabrand or another agency? Bring us the same questions. A serious partner should be willing to answer them.